Description
Tirzepatide 30mg provides a high-yield supply for large-scale or multi-phase laboratory research. As a dual GLP-1 and GIP receptor agonist, tirzepatide continues to be among the most actively studied compounds in metabolic research. This format accommodates extended study designs and repeat-experiment protocols.
Independently batch-tested to 99%+ purity via HPLC and MS/MS. Full COA included.
For research use only. Not for human or veterinary consumption.




